DV Biologics to Exhibit Next-Gen Biological Tool at EB2015

EB-2015-logoBoston, MA, March 23, 2015 – Please join us on March 28, 2015 through April 1, 2015 at the Boston Convention and Exhibition Center for the Experimental Biology 2015 convention. Stop by our booth #166 for the latest in cell based CELLutions and to see the next-gen biological tool.

A recent report, 3D Cell Cultures: Technologies and Global Markets; reveals the global three-dimensional (3D) cell culture market is expected to grow to $2.2 billion by 2019, with a five-year compound annual growth rate (CAGR) of 30.1%. Significant growth within the biopharmaceuticals industry is spurring unprecedented innovation and demand for cell culture products for the purposes of drug discovery and safety testing. Fueled by toxicity testing and increased biopharmaceutical production, we have optimized our product line to match this growing trend and cater to the industry’s evolving needs. Human derived-tissues include:
– Oncology and Cancer Portfolios
– Kidney Fibrosis 
– CD133+ / CD34+ Cellular, Genomic and Proteomic Liver Samples

“Growth in this industry will be driven by rising R&D spending…soaring biopharmaceutical production, and increasing instances of cancer and liver-related issues,” said BCC Research biotechnology analyst Robert Hunter.

This entry was posted in DV Biologics News, Events. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *